FI852340L - Dihydropyridin som medel mot blodbrist och blodtryck. - Google Patents

Dihydropyridin som medel mot blodbrist och blodtryck.

Info

Publication number
FI852340L
FI852340L FI852340A FI852340A FI852340L FI 852340 L FI852340 L FI 852340L FI 852340 A FI852340 A FI 852340A FI 852340 A FI852340 A FI 852340A FI 852340 L FI852340 L FI 852340L
Authority
FI
Finland
Prior art keywords
blodtryck
blodbrist
medel
dihydropyridin
som
Prior art date
Application number
FI852340A
Other languages
English (en)
Finnish (fi)
Other versions
FI852340A0 (fi
Inventor
David Alker
Simon Fraser Campbell
Peter Edward Cross
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI852340A0 publication Critical patent/FI852340A0/fi
Publication of FI852340L publication Critical patent/FI852340L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FI852340A 1984-06-15 1985-06-12 Dihydropyridin som medel mot blodbrist och blodtryck. FI852340L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848415386A GB8415386D0 (en) 1984-06-15 1984-06-15 Therapeutic agents

Publications (2)

Publication Number Publication Date
FI852340A0 FI852340A0 (fi) 1985-06-12
FI852340L true FI852340L (fi) 1985-12-16

Family

ID=10562530

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852340A FI852340L (fi) 1984-06-15 1985-06-12 Dihydropyridin som medel mot blodbrist och blodtryck.

Country Status (11)

Country Link
EP (1) EP0165032A3 (no)
JP (1) JPS617276A (no)
KR (1) KR860000285A (no)
AU (1) AU4368985A (no)
DK (1) DK269885A (no)
FI (1) FI852340L (no)
GB (1) GB8415386D0 (no)
GR (1) GR851447B (no)
HU (1) HUT37934A (no)
IL (1) IL75507A0 (no)
PT (1) PT80630B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1213555B (it) * 1986-12-11 1989-12-20 Boehringer Biochemia Srl 2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7910521L (sv) * 1979-12-20 1981-06-21 Haessle Ab Nya 2-metyl-6-substituerade-4-(2,3-disubstituerad fenyl)-1,4-dihydropyridin-3,5-diestrar med hypotesiva egenskaper, samt forfarande for deras framstellning, och farmaceutiska beredningar innehallande desamma
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
DE3363743D1 (en) * 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents
EP0107293A3 (en) * 1982-09-04 1984-06-06 Pfizer Limited Dihydropyridines
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
US4515799A (en) * 1983-02-02 1985-05-07 Pfizer Inc. Dihydropyridine anti-ischaemic and antihypertensive agents

Also Published As

Publication number Publication date
PT80630A (en) 1985-07-01
PT80630B (en) 1987-04-28
KR860000285A (ko) 1986-01-27
GB8415386D0 (en) 1984-07-18
EP0165032A3 (en) 1987-06-16
IL75507A0 (en) 1985-10-31
AU4368985A (en) 1985-12-19
GR851447B (no) 1985-11-25
FI852340A0 (fi) 1985-06-12
JPS617276A (ja) 1986-01-13
DK269885D0 (da) 1985-06-14
DK269885A (da) 1985-12-16
EP0165032A2 (en) 1985-12-18
HUT37934A (en) 1986-03-28

Similar Documents

Publication Publication Date Title
FI862256A (fi) Grundmjukgoerare som innehaoller katjoniskt ytaktivt medel och organisk syra.
FI861251A (fi) Foerfarande foer extrahering och rengoering av proteiner fraon en kultur som producerar dessa.
FI853220A0 (fi) Aminoalkoxibensopyranoner som antipsykotiska och anxiolytiska aemnen.
FI862059A (fi) Aminomalonylalanfoereningar och deras anvaendning som dietetiska soetningsmedel.
FI853383L (fi) Kompositioner som uppmjukar tvaettmedlet under tvaettcykeln och foerbaettrar tygets soliditet.
FI863335A0 (fi) Hydrokrackningskatalysatorer och foerfaranden som utnyttjar molekylaersaoll av silikoaluminofosfat.
FI854919A0 (fi) Aminoacylabdaner, foerfarande och mellanprodukter foer deras framstaellning och deras anvaendning som laekemedel.
FI865168A0 (fi) Tillaeggsaemnesfoerening som foerbaettrar kallfloede och braenslekomposition innehaollande densamma.
FI861623A (fi) Aktivt vaete innehaollande komposition, som innehaoller tertiaert dialkanolamin och framstaellningsfoerfarande foer polyuretanskum.
FI863155A (fi) Foerfarande foer framstaellning av kefalosporinsalter och injekterbara kompositioner som innehaoller detsamma.
FI860981A0 (fi) Heterocykliska sulfider och deras anvaendning som immunomodulatorer.
FI853854A0 (fi) Jodtriaminobenzenfoereningar, foerfarande foer deras framstaellning och deras anvaendning som kontrastmedel foer roentgenstraolar.
FI883315A0 (fi) 1h-pyrazol-1-alkanamider anvaendbara som antiarrytmiska medel och deras framstaellning.
FI833046A (fi) Haeftande medel foer brandsaekring och fiberinkapsling.
FI875707A0 (fi) Mycket fyllaemne innehaollande fenolhartsskumplaster och deras anvaendning som isolerformkroppar.
FI864623A0 (fi) Doftande vaeggbeklaednad som innehaoller mjukgoeraranfuktningsmedel och foerfarande foer dess framstaellning.
FI842578A0 (fi) Foerfarande foer avlaegsning och tillvaratagande av svavel som grundaemnessvavel fraon svaveldioxid - eller svaveldioxid och svavelvaetehaltiga gaser.
FI860980A (fi) Heterocykliska disulfider och deras anvaendning som immunmodulatorer.
FI852340L (fi) Dihydropyridin som medel mot blodbrist och blodtryck.
FI842197A (fi) Anvaendningsfoerfarande och anordning som utestaenger en samkaella.
FI860866A0 (fi) Anordning som uppbaer och visar paosar.
FI860224A (fi) Dihydropyridin anvaendbart saosom blodbrist och hoegt blodtryck foerhindrande medel.
FI852888L (fi) Foerfarande och medel foer skydd av plantor mot insektsangrepp.
FI852729A0 (fi) Ammoniumsalter haerledda fraon hexahydrodibenzodioxan, deras mellanprodukter, framstaellning och anvaendning som laekemedel.
FI853883A0 (fi) Foerfarande foer regenerering av asfaltbetongbelaeggningar och en foer genomfoerande av foerfarandet avsedd mataranordning foer ett medel som aoterstaeller asfaltbetongens egenskaper.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: PFIZER CORPORATION